Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease - PubMed

Affiliations

• PMID: 29050382
• DOI: 10.1093/brain/awx171

Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease

Michael Schöll et al. Brain. 2017.

Abstract

Patients with Alzheimer's disease can present with different clinical phenotypes. Individuals with late-onset Alzheimer's disease (>65 years) typically present with medial temporal lobe neurodegeneration and predominantly amnestic symptomatology, while patients with early-onset Alzheimer's disease (<65 years) exhibit greater neocortical involvement associated with a clinical presentation including dyspraxia, executive dysfunction, or visuospatial impairment. We recruited 20 patients with early-onset Alzheimer's disease, 21 with late-onset Alzheimer's disease, three with prodromal early-onset Alzheimer's disease and 13 with prodromal late-onset Alzheimer's disease, as well as 30 cognitively healthy elderly controls, that had undergone 18F-AV-1451 tau positron emission tomography and structural magnetic resonance imaging to explore whether early- and late-onset Alzheimer's disease exhibit differential regional tau pathology and atrophy patterns. Strong associations of lower age at symptom onset with higher 18F-AV-1451 uptake were observed in several neocortical regions, while higher age did not yield positive associations in neither patient group. Comparing patients with early-onset Alzheimer's disease with controls resulted in significantly higher 18F-AV-1451 retention throughout the neocortex, while comparing healthy controls with late-onset Alzheimer's disease patients yielded a distinct pattern of higher 18F-AV-1451 retention, predominantly confined to temporal lobe regions. When compared against each other, the early-onset Alzheimer's disease group exhibited greater uptake than the late-onset group in prefrontal and premotor, as well as in inferior parietal cortex. These preliminary findings indicate that age may constitute an important contributor to Alzheimer's disease heterogeneity highlighting the potential of tau positron emission tomography to capture phenotypic variation across patients with Alzheimer's disease.

Keywords: Alzheimer’s disease; age-at-onset; atrophy; positron emission tomography; tau.

Similar articles

• Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

  Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. Ossenkoppele R, et al. Brain. 2016 May;139(Pt 5):1551-67. doi: 10.1093/brain/aww027. Epub 2016 Mar 8. Brain. 2016. PMID: 26962052 Free PMC article.

• Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.

  Tosun D, Landau S, Aisen PS, Petersen RC, Mintun M, Jagust W, Weiner MW; Alzheimer’s Disease Neuroimaging Initiative. Tosun D, et al. Brain. 2017 May 1;140(5):1499-1512. doi: 10.1093/brain/awx046. Brain. 2017. PMID: 28334939

• Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.

  Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini ML, Miller ZA, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Bejanin A, et al. Brain. 2017 Dec 1;140(12):3286-3300. doi: 10.1093/brain/awx243. Brain. 2017. PMID: 29053874 Free PMC article.

• Tau PET imaging: present and future directions.

  Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A. Saint-Aubert L, et al. Mol Neurodegener. 2017 Feb 20;12(1):19. doi: 10.1186/s13024-017-0162-3. Mol Neurodegener. 2017. PMID: 28219440 Free PMC article. Review.

• Developments in Tau PET Imaging.

  Zimmer ER, Leuzy A, Gauthier S, Rosa-Neto P. Zimmer ER, et al. Can J Neurol Sci. 2014 Sep;41(5):547-53. doi: 10.1017/cjn.2014.15. Can J Neurol Sci. 2014. PMID: 25424608 Review.

Cited by

• Early-onset Alzheimer's disease shows a distinct neuropsychological profile and more aggressive trajectories of cognitive decline than late-onset.

  Tort-Merino A, Falgàs N, Allen IE, Balasa M, Olives J, Contador J, Castellví M, Juncà-Parella J, Guillén N, Borrego-Écija S, Bosch B, Fernández-Villullas G, Ramos-Campoy O, Antonell A, Rami L, Sánchez-Valle R, Lladó A. Tort-Merino A, et al. Ann Clin Transl Neurol. 2022 Dec;9(12):1962-1973. doi: 10.1002/acn3.51689. Epub 2022 Nov 17. Ann Clin Transl Neurol. 2022. PMID: 36398437 Free PMC article.

• Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity.

  Pereira JB, Ossenkoppele R, Palmqvist S, Strandberg TO, Smith R, Westman E, Hansson O. Pereira JB, et al. Elife. 2019 Dec 9;8:e50830. doi: 10.7554/eLife.50830. Elife. 2019. PMID: 31815669 Free PMC article.

• Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease.

  Visser D, Verfaillie SCJ, Wolters EE, Coomans EM, Timmers T, Tuncel H, Boellaard R, Golla SSV, Windhorst AD, Scheltens P, van der Flier WM, van Berckel BNM, Ossenkoppele R. Visser D, et al. Eur J Nucl Med Mol Imaging. 2022 May;49(6):1951-1963. doi: 10.1007/s00259-021-05669-6. Epub 2022 Jan 8. Eur J Nucl Med Mol Imaging. 2022. PMID: 34997294 Free PMC article.

• Implication of tau propagation on neurodegeneration in Alzheimer's disease.

  Lamontagne-Kam D, Ulfat AK, Hervé V, Vu TM, Brouillette J. Lamontagne-Kam D, et al. Front Neurosci. 2023 Jul 7;17:1219299. doi: 10.3389/fnins.2023.1219299. eCollection 2023. Front Neurosci. 2023. PMID: 37483337 Free PMC article. Review.

• A global view of the genetic basis of Alzheimer disease.

  Reitz C, Pericak-Vance MA, Foroud T, Mayeux R. Reitz C, et al. Nat Rev Neurol. 2023 May;19(5):261-277. doi: 10.1038/s41582-023-00789-z. Epub 2023 Apr 6. Nat Rev Neurol. 2023. PMID: 37024647 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information